Skip to main content
. 2014 Dec 23;1(3):e963441. doi: 10.4161/23723548.2014.963441

Figure 1.

Figure 1.

Gain-of-function mutant p53 inhibits adenosine monophosphate-activated protein kinase (AMPK) activation in head and neck squamous cell carcinoma. The wild-type p53 protein functions indirectly both upstream and downstream of AMPK. The gain-of-function mutant p53 functions directly upstream of AMPK and inhibits its activation, impairing the metabolic checkpoint and increasing anabolic tumor growth and progression.